Exam
opens on June 1,
2018
To enroll
for
exam, and pay via credit card directly, click here
.
Download
Rabex
2018 Registration Form
Table of contents, Rabex future, & history
, Email to ----->
info@rabex.net
The purpose of RABEX: The Radiation and Cancer
Biology Practice Examination is to supplement the training
of radiation oncology residents by providing an
educational resource to help guide residents in the study of cancer
and radiation
biology. It is anticipated that the Radiation and Cancer Biology
Practice
Examination will also assist residents and board eligible radiation
oncologists in preparation for the Radiation and Cancer
Biology section of
the cognitive
exam
administered by the
American Board of Radiology
(ABR)
for certification in radiation oncology.
Well into its second
decade of existence, RABEX continues to be a unique and
important educational
tool for the certification and continuous education of residents and
senior radiation oncologists. The
present edition of RABEX follows the original goals defined in
the 1990’s by Drs. J. D. Chapman, S.
Shahabi, L. R. Coia and B. Corn. However, due to the
increase in knowledge in the field of biology and
the rapid development of electronic distribution of information,
RABEX needed to
be updated to match
these challenges. The ultimate goal of the present edition is to
maintain its level of excellence with
relevant updates in topics and contents.
The topics included in the
RABEX practice examination continue to be
based upon those listed by
the American Board of Radiology for the cognitive exam in
radiation
and cancer biology. Also, the number
of questions in each section reflects the ABR's relative weight for
each topic. Therefore, this practice
examination provides guidance for residents and senior radiation
oncologists in their preparation for
the initial radiation oncology certification examination as well as to
demonstrate cognitive expertise in
radiation biology required for maintenance of certification.
The exam consists
of 200 multiple choice questions in, ABR format: Molecular
mechanisms of DNA damage and repair; chromosome and
chromatid damage; mechanisms
of cell death; cell survival models; LET and RBE; oxygen effect;
repair at the
cellular level; tumor microenvironment; cell and tissue kinetics;
molecular signaling;
cancer biology; total body irradiation; clinical and mechanistic
responses to
radiation of normal tissues; therapeutic ratio; time, dose and
fractionation;
brachytherapy; alternative radiation modalities; chemotherapeutic
agents; radiosensitizers,
bioreductive drugs and radioprotectors; hyperthermia; radiation
carcinogenesis;
heritable effects of radiation; radiation effects in the developing
embryo; radiation
protection, Radiologic Terrorism, & Molecular Imaging.
The answer, along with an
explanation and
appropriate reference, will
be provided for each question.
Editor-in-
Chief:
Marcelo Vazquez, MD,
PhD
Loma
Linda University, Radiation Medicine
MVazquez@llu.edu
Chief-
Technical Editor:
Siamak Shahabi, PhD
Rabex
Organization & Advanced Medical Publishing, Inc.
info@rabex.net
Contributors:
Marcelo Vazquez, PhD, Lead,
Clinical
Translational Radiobiology Research Dept. of Radiation
Medicine Loma
Linda University Medical Center, CA, Gary Y. Yang, MD, Editor-in-
Chief, Journal of
Gastrointestinal Oncology (JGO), President, Society
for
Gastrointestinal Oncology (SGO), Department of Radiation
Medicine, Loma Linda University Medical
Center, Loma
Linda, CA, Omar Y. Mian, MD, PhD,
Department of
Translational Hematology & Oncology Research (THOR) |
Department of Radiation Oncology |
Cleveland Clinic, Cleveland, OH,
Kathryn Huber, MD, PhD
, Radiation
Oncology, Director, Department of Radiation
Oncology, Radiation Oncology Training Program, Tufts
Medical Center, Boston, MA, Erica Bell, PhD, Radiation
Oncology, Director, Department of Radiation Oncology, Radiation
Oncology Training Program, Ohio State University, Columbus, OH,
Jessica Fleming,
PhD, Radiation
Oncology, Director, Department of Radiation Oncology, Radiation
Oncology Training Program, Ohio State University, Columbus,
OH, Mark Ritter, MD, University of Wisconsin, Department of Radiation
Oncology,
Madison, WI, Minesh Metha, MD, Deputy director and chief of Radiation Oncology at
Miami Cancer Institute at Baptist Health South Florida,
Richar
Miller, PhD, University of
Chicago, Chicago, Cell Biology, Cancer Research, Accelerator
Physics, & Siamak Shahabi, PhD, Chief-Technical Editor, Rabex
Organization & Advanced Medical Publishing, Inc., and
Cancer-Matrix Manual, USA.
Past
Contributors:
1995-1999
J.D. Chapman, PhD, Editor-in-Chief
Associate
Editors Joan
Allalunis-Turner, PhD, Paul C. Billings, PhD, David A. Boothman,
PhD,
J. Martin Brown, PhD, Lawrence R. Coia, MD, William C. Dewey,
PhD, Evan
B. Douple, PhD, Richard P. Hill, PhD, Clifton C. Ling, PhD, Luka
Milas,
PhD, William F. Morgan, PhD., Colin G. Orton, PhD, Mark A. Ritter,
MD,
PhD, Sara Rockwell, Barry S. Rosenstein, PhD, Joseph L.
Roti
Roti, PhD,
Craig W. Stevens, MD, Beverly A. Teicher, PhD, E. Day Werts, PhD,
& H. Rodney Withers, PhD.
|